Onward medical awarded grant to study potential for arc-bci therapy to restore movement after stroke

Grant supports the first clinical trials studying the potential for brain-computer interface (bci) and artificial intelligence (ai) technology to restore thought-driven movement after stroke funding also supports technology development of arc-bci system and arc-im lead approximately 15 million people worldwide experience a stroke each year eindhoven, the netherlands, nov. 19, 2024 (globe newswire) -- onward medical n.v. (euronext: onwd), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (sci), today announces a grant from the european innovation council (eic) to study the use of its investigational arc-bci therapy to restore upper limb movement after subcortical stroke.
ARC Ratings Summary
ARC Quant Ranking